{"id":8084,"date":"2023-05-09T19:00:11","date_gmt":"2023-05-09T17:00:11","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/05\/Vedanta-Biosciences-Receives-Fast-Track-Designation-for-VE303-and-Presents-Phase-2-Data-at-Digestive-Disease-Week.pdf"},"modified":"2023-05-09T19:00:11","modified_gmt":"2023-05-09T17:00:11","slug":"vedanta-biosciences-receives-fast-track-designation-for-ve303-and-presents-phase-2-data-at-digestive-disease-week","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/vedanta-biosciences-receives-fast-track-designation-for-ve303-and-presents-phase-2-data-at-digestive-disease-week\/vedanta-biosciences-receives-fast-track-designation-for-ve303-and-presents-phase-2-data-at-digestive-disease-week\/","title":{"rendered":"Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8084","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n